Patents for C07C 405 - Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins (3,702) |
---|
07/01/1999 | WO1999032441A1 13-oxa prostaglandins for the treatment of glaucoma and ocular hypertension |
05/27/1999 | WO1999025358A1 Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
05/27/1999 | CA2310630A1 Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
05/25/1999 | US5906989 Cyclopentane(ENE) heptenoic or heptanoic acids and derivatives thereof useful as therapeutic agents |
05/06/1999 | WO1999021830A1 Process for stereoselective synthesis of prostacyclin derivatives |
05/06/1999 | EP0912507A1 Cyclopentan(en)oic acid, 2-alkenyl derivatives as therapeutic agents in the treatment of ocular hypertension |
05/06/1999 | CA2847985A1 Process for stereoselective synthesis of prostacyclin derivatives |
05/06/1999 | CA2307163A1 Process for stereoselective synthesis of prostacyclin derivatives |
04/28/1999 | EP0737184B1 Cyclopentane(ene) heptenoic or heptanoic acids and derivatives thereof useful as therapeutic agents |
04/13/1999 | CA2099667C Agent for treating hepatic diseases |
04/06/1999 | US5892099 Autoimmune disease, bone disorders, liver damage, cardiovascular disorders |
04/06/1999 | US5891910 Cytoprotective drugs |
03/30/1999 | US5889052 Use of cloprostenol and fluprostenol analogues to treat glaucoma and ocular hypertension |
03/30/1999 | CA2144313C 4-hydroxy-2-cyclopentenone derivative and carcinostatic and osteogenesis promoter containing the same |
03/23/1999 | US5886035 Difluoroprostaglandin derivatives and their use |
03/23/1999 | US5886034 Antiulcer agents |
03/18/1999 | WO1999012899A1 A process for making prostaglandin f analogs |
03/18/1999 | WO1999012898A1 Aromatic c16-c20-substituted tetrahydro prostaglandins useful as fp agonists |
03/18/1999 | WO1999012897A1 A process for making epoxide intermediates |
03/18/1999 | WO1999012896A1 Aromatic c16-c20-substituted tetrahydro prostaglandins useful as fp agonists |
03/18/1999 | WO1999012895A1 Aromatic c16-c20-substituted tetrahydro prostaglandins useful as fp agonists |
03/18/1999 | WO1998058911A3 Prostaglandin agonists |
03/18/1999 | CA2303797A1 A process for making epoxide intermediates |
02/25/1999 | WO1998052915A3 Leukotriene b4 derivatives, in particular oximo-ltb4 antagonists |
02/25/1999 | WO1998052912A3 Leukotriene b4 antagonists, in particular 3-carba-tetrahydronaphthalene-ltb4 antagonists |
02/23/1999 | US5874634 Substituted cyclopentene derivatives and method for preparing the same |
02/02/1999 | US5866602 Keto-substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives |
12/30/1998 | WO1998058911A2 Prostaglandin agonists |
12/30/1998 | WO1998058910A1 Prostaglandin pharmaceutical compositions |
12/24/1998 | DE19722846A1 Leukotrien-B¶4¶-Derivate, insbesondere 7-Methylcyclohexyl-LTB¶4¶-Antagonisten Leukotriene B¶4¶ derivatives, in particular 7-methylcyclohexyl-LTB¶4¶ antagonists |
12/23/1998 | WO1998057930A1 Keto-substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives |
12/15/1998 | US5849791 Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension |
12/10/1998 | DE19722853A1 Leukotrien-B¶4¶-Antagonisten, insbesondere 3-Carba-Tetrahydronaphthalin-LTB¶4¶-Antagonisten B¶4¶ leukotriene antagonists, in particular 3-carba-tetrahydronaphthalene-LTB¶4¶ antagonists |
12/10/1998 | DE19722845A1 Leukotrien-B¶4¶-Derivate, insbesondere Interphenylen-7-Methylcyclohexyl-LTB¶4¶-Antagonisten Leukotriene B¶4¶ derivatives, in particular interphenylene 7-methylcyclohexyl-LTB¶4¶ antagonists |
12/08/1998 | CA2030345C Use of 15-keto-prostaglandin compound for improvement of encephalic function |
11/26/1998 | WO1998052916A1 Novel leukotriene-b derivatives, method for the production and use thereof |
11/26/1998 | WO1998052915A2 Leukotriene b4 derivatives, in particular oximo-ltb4 antagonists |
11/26/1998 | WO1998052914A1 Leukotriene b4 derivatives, in particular 7-methylcyclohexyl-ltb4 antagonists |
11/26/1998 | WO1998052912A2 Leukotriene b4 antagonists, in particular 3-carba-tetrahydronaphthalene-ltb4 antagonists |
11/26/1998 | DE19722848A1 Leukotrien-B¶4¶-Derivate, insbesondere Oximo-LTB¶4¶-Antagonisten Leukotriene B¶4¶ derivatives, in particular oximo-LTB¶4¶ antagonists |
11/26/1998 | CA2291123A1 Leukotriene b4 derivatives, in particular oximo-ltb4 antagonists |
11/26/1998 | CA2291112A1 Leukotriene b4 derivatives, in particular 7-methylcyclohexyl-ltb4 antagonists |
11/05/1998 | WO1998039293A3 13-thia prostaglandins for use in glaucoma therapy |
11/04/1998 | EP0874816A1 Process for the preparation of prostaglandin e1 |
10/28/1998 | EP0716648B1 New 9-chloro-prostaglandin derivatives |
10/06/1998 | US5817694 Oxytocics |
09/30/1998 | CN1194266A Omega-naphthenic base prostaglandin E2 derivatives |
09/29/1998 | CA2176763C Misoprostol |
09/15/1998 | US5807892 Use of certain prostaglandin analogues to treat glaucoma and ocular hypertension |
09/11/1998 | WO1998039293A2 13-thia prostaglandins for use in glaucoma therapy |
09/11/1998 | CA2276666A1 13-thia prostaglandins for use in glaucoma therapy |
08/26/1998 | EP0860430A2 Omega-cycloalkyl-prostaglandin E2 derivatives |
08/25/1998 | US5798378 Treatment of ocular hypertension |
08/20/1998 | WO1998020880A3 11-Halo prostaglandins for the treatment of glaucoma or ocular hypertension |
08/18/1998 | US5795914 Phenylalkan(en)oic acid |
08/13/1998 | WO1998034916A1 11,15-o-dialkylprostaglandin e derivatives, process for producing the same, and drugs containing the same as the active ingredient |
08/04/1998 | CA2228828A1 Omega-cycloalkyl-prostaglandin e2 derivatives |
07/29/1998 | EP0855389A2 A 3,7-dithiaprostanoic acid derivative |
07/21/1998 | US5783602 Leukotriene-B4 derivatives, process for their production and their use as pharmaceutical agents |
07/16/1998 | WO1998021181A3 15-fluoro prostaglandins as ocular hypotensives |
07/15/1998 | CN1187486A Difluoroprostaglundin Derivatives and their use |
07/01/1998 | EP0850926A2 Difluoroprostaglandin derivatives and their use |
06/30/1998 | US5773654 7-(5-substituted cyclopentyl) and (5-substituted cyclopentenyl) heptyl alcohols, heptylamines and heptanoic acid amides, and method of lowering intraocular pressure in the eye of a mammal by administration of these compounds |
06/25/1998 | WO1998021182A3 Use of cis-δ4 analogs of prostaglandins as ocular hypotensives |
06/23/1998 | US5770759 13,14-dihydro-15-keto-pgf's; vasopressors |
06/17/1998 | EP0847276A2 Method for effecting vasodilation with (1,5-inter)aryl prostaglandin derivatives |
05/27/1998 | EP0656889B1 9-chloroprostaglandin esters and amides and their use in the preparation of drugs |
05/26/1998 | US5756818 Hydrogenation; protecting; deprotecting; clathrates |
05/22/1998 | WO1998021182A2 Use of cis-δ4 analogs of prostaglandins as ocular hypotensives |
05/22/1998 | WO1998021181A2 15-fluoro prostaglandins as ocular hypotensives |
05/22/1998 | WO1998021180A1 Conformationally rigid aryl- or heteroaryl prostaglandins for use in glaucoma therapy |
05/22/1998 | WO1998021179A1 Process for the preparation of prostaglandins |
05/22/1998 | WO1998020880A2 11-halo prostaglandins for the treatment of glaucoma or ocular hypertension |
05/22/1998 | CA2271035A1 Process for the preparation of prostaglandins |
05/22/1998 | CA2269855A1 15-fluoro prostaglandins as ocular hypotensives |
05/22/1998 | CA2269853A1 Use of cis-.delta.4 analogs of prostaglandins as ocular hypotensives |
05/20/1998 | CN1182136A Production technology of material medicine for prostaglandin E1 |
05/13/1998 | EP0627416B1 Process for producing prostaglandin e |
05/12/1998 | US5750784 Method for effecting vasodilation with (1,5-inter) aryl prostaglandin derivatives |
04/22/1998 | EP0741686B1 New leukotriene b4 derivatives, methods of preparing them and their use as drugs |
04/14/1998 | US5739161 Prostaglandins; diarrhea side effect reduction |
04/08/1998 | EP0562006B1 Homo-prostaglandin derivatives as ocular hypotensives |
04/07/1998 | CA2003260C Process for the production of carbacyclin derivatives by stereoselective introduction of the 5,6 double bond |
04/01/1998 | CN1177956A Process for preparing prostaglandin E1, E2 and analogs thereof using furylcopper reagents |
03/26/1998 | WO1998012175A1 Fluorinated prostaglandin derivatives and medicines |
03/24/1998 | US5731452 7-thiaprostaglandins and method of production thereof |
03/04/1998 | EP0825980A1 Cyclopentane heptan(ene)oic acid, 2-heteroarylakenyl derivatives as therapeutic agents for the treatment of ocular hypertension |
02/24/1998 | US5721273 Use of certain 9-halo-13,14-dihydroprostaglandins to treat glaucoma and ocular hypertension |
02/10/1998 | US5716989 Bicyclo 3.3.0!octane derivatives, process for their production and their pharmaceutical use |
01/27/1998 | CA2037009C 15-dehydroxy-16-oxoprostaglandins |
01/07/1998 | EP0815076A1 Process for preparing prostaglandin e1, e2 and analogs thereof using furylcopper reagents |
12/16/1997 | US5698733 Use of 9-deoxy prostaglandin derivatives to treat glaucoma |
12/16/1997 | US5698590 Treatment of peripheral circulatory disorders and ulcers and for blood flow maintenance after surgery |
12/04/1997 | WO1997045405A1 Cyclopentan(en)oic acid, 2-alkenyl derivatives as therapeutic agents in the treatment of ocular hypertension |
12/04/1997 | CA2256404A1 Cyclopentan(en)oic acid, 2-alkenyl derivatives as therapeutic agents in the treatment of ocular hypertension |
11/25/1997 | US5690957 Prostaglandin derivatives |
11/19/1997 | EP0807634A2 Misoprostol, process for its preparation using an organometallic cuprate complex |
11/18/1997 | US5688819 Cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents |
11/04/1997 | US5684177 Preparing an organometallic cuprate complex carrying an organic unsaturated ligand |
10/29/1997 | CN1163568A Use of 9-deoxy prostaglandin derivatives to treat glaucoma |